共 164 条
[11]
Hunot S(2002)The interleukin-10 family of cytokines Trends Immunol 23 89-96
[12]
Mosley RL(2003)Interleukin-10 as a CNS therapeutic: the obstacle of the blood–brain/blood–spinal cord barrier Brain Res Mol Brain Res 114 168-71
[13]
Benner EJ(2008)Human interleukin-10 gene transfer is protective in a rat model of Parkinson’s disease Mol Ther 16 1392-9
[14]
Kadiu I(2010)Time course of changes in the concentrations of amino acids in the brain structures of pentylenetetrazole-kindled rats Brain Res 1342 150-9
[15]
Thomas M(1995)Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with ophthalaldehyde-sulphite derivatisation J Neurosci Meth 57 93-9
[16]
Boska MD(2009)Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Brain Res 1261 7-19
[17]
Hasan K(2007)Influence of age and gender on cytokine expression in a murine model of Parkinson’s disease Neuroimmunomodulation 14 255-65
[18]
Qian L(2007)Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra Neurobiol Aging 28 894-906
[19]
Flood PM(2006)Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10 J Neural Transm Suppl 70 367-71
[20]
Hong JS(2003)Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia Cell Biochem Biophys 39 13-22